PLRX Q3 2022 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$82M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-8.0% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$32M-2155.7% margin

Net Income

-$31M-2065.8% margin

EPS (Diluted)

$-0.60

QoQ Revenue Growth

-70.3%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$377M

Total Liabilities

$40M

Stockholders' Equity

$337M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$2M	-8.0%
Gross Profit	$1M	$2M	-8.0%
Operating Income	-$32M	-$27M	-17.8%
Net Income	-$31M	-$27M	-13.2%